CVS Health (CVS) Fundamental Analysis: Revenue, Earnings & Valuation

5.75 / 10

Netural

Fundamental analysis rates CVS as fair (5.8/10). Strengths include high Cash‑MV (0.74) and net operating cash flow (2.65% of revenue). Asset‑liability ratio is acceptable (70%). Weak points are low interest coverage (1.68) and modest current‑asset turnover (5.61), suggesting selective caution.

Analysis Checks(4/10)

ROA (%)

Value0.68

Score1/3

Weight3.88%

1M Return1.32%

Asset-liability ratio (%)

Value70.27

Score3/3

Weight24.71%

1M Return8.77%

Net cash flow from operating activities / Operating revenue (%)

Value2.65

Score2/3

Weight7.42%

1M Return2.43%

Net income-Revenue

Value-0.86

Score1/3

Weight4.95%

1M Return1.89%

Current assets turnover ratio

Value5.61

Score1/3

Weight4.93%

1M Return1.74%

Annualized net profit margin on total assets (%)

Value0.68

Score1/3

Weight3.88%

1M Return1.32%

Interest coverage ratio (EBIT / Interest expense) (%)

Value1.68

Score0/3

Weight-1.86%

1M Return-0.73%

ROE (diluted) (%)

Value2.35

Score1/3

Weight0.91%

1M Return0.34%

EBIT / Total operating revenue (%)

Value1.31

Score3/3

Weight25.82%

1M Return8.15%

Cash-MV

Value0.74

Score3/3

Weight25.37%

1M Return8.40%

Is CVS undervalued or overvalued?

CVS scores 5.75/10 on fundamentals and holds a Fair valuation at present. Backed by its 2.34% ROE, 0.43% net margin, 52.39 P/E ratio, 1.23 P/B ratio, and -61.85% earnings growth, these metrics solidify its Netural investment rating.